Global 5G In Healthcare Market Size and Share

5G in Healthcare Market Summary
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Global 5G In Healthcare Market Analysis by Mordor Intelligence

The 5G in healthcare market size was valued at USD 95.26 billion in 2025 and estimated to grow from USD 123.59 billion in 2026 to reach USD 454.43 billion by 2031, at a CAGR of 29.74% during the forecast period (2026-2031). Rapid scale-up from pilot projects to full commercial rollouts is accelerating demand, as millisecond-level latency unlocks remote surgery, real-time intensive-care collaboration, and high-resolution medical imaging. Hardware still attracts the largest capital outlay, yet managed service models are surging as hospitals seek turnkey deployments that avoid specialist staffing burdens. Regional momentum diverges: North America leans on private networks for mission-critical workloads, while Asia-Pacific gains speed through public-private build-outs that lower infrastructure costs. Spectrum pricing reform, tighter cybersecurity frameworks, and maturing edge-compute ecosystems will shape the competitive landscape—and determine how quickly the 5G in healthcare market captures untapped connectivity budgets.

Key Report Takeaways

  • By geography, North America accounted for 39.78% of 5G in healthcare market share in 2025, whereas Asia-Pacific is projected to expand at the fastest 34.08% CAGR to 2031.
  • By component, hardware led with 50.12% revenue share in 2025; services are poised for the highest 32.07% CAGR through 2031.
  • By communication type, eMBB captured 51.85% share of the 5G in healthcare market size in 2025; URLLC is forecast to progress at a 32.12% CAGR between 2026-2031.
  • By application, telemedicine and virtual consultation services held 34.02% of 5G in healthcare market size in 2025, while robotic & telesurgery is advancing at a 32.75% CAGR to 2031.
  • By end user, hospitals and surgical centers commanded 45.83% market share in 2025; home healthcare is the fastest-growing user segment at 33.41% CAGR through 2031

Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026.

Segment Analysis

By Component: Hardware Dominance Drives Infrastructure Build-out

Hardware solutions commanded 50.12% of the 5G in healthcare market share in 2025, reflecting the heavy capital requirements of base stations, small cells, antennas, and edge servers. Early adopters treated connectivity as a construction project, funding multiyear campus overhauls that underpin surgical suites, imaging labs, and intensive-care units. Yet the services slice is scaling faster—32.07% CAGR—because hospitals prefer turnkey subscriptions that bundle spectrum, software, and compliance services. ZTE’s integrated 5G IoT network for Soochow University Hospital connected 3,000 devices, trimmed build time 90%, and cut total cost of ownership 30%. Similar “network-as-a-service” models shift 5G in healthcare market risk off hospital balance sheets, encourage phased adoption, and spur ecosystem innovation.

That migration reshuffles vendor power. Infrastructure OEMs partner with cloud hyperscalers and cybersecurity firms to defend margins, while integrators monetise lifecycle management. Hospitals gain predictable opex, on-demand network slices, and embedded threat monitoring. Over 2026-2031, managed services could eclipse hardware shipments in annual spend, marking a structural pivot within the 5G in healthcare market.

Global 5G in Healthcare Market: Market Share by Component, 2025
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Global 5G in Healthcare Market: Market Share by Component, 2025

By Communication Type: eMBB Leads While URLLC Accelerates

Enhanced Mobile Broadband (eMBB) secured 51.85% share of the 5G in healthcare market size in 2025 by supporting 4K imaging, high-definition conferencing, and cloud PACS back-ups. Demand remains sticky as radiology departments shift to 8K workflows and medical schools stream volumetric video for remote training. Ultra-Reliable Low-Latency Communications (URLLC) races ahead at 32.12% CAGR, enabling precision robotics, AI-guided anaesthesia, and multi-site stroke intervention units. Singapore’s National University Health System recorded 1 Gbps downlink, 150 Mbps uplink, and sub-10 ms latency across 20 mixed-reality surgeries on 3.5 GHz spectrum. Massive Machine-Type Communications (mMTC) underpins billions of low-power sensors, from drug refrigerators to connected wearables, forming the glue for continuous care loops.

Inter-slice orchestration is emerging as the competitive pivot: vendors that seamlessly flex bandwidth between eMBB diagnostic transfers and URLLC surgical sessions will win enterprise contracts. Regulators now standardise quality-of-service thresholds, pushing suppliers to validate latency and jitter across complex hospital floorplans. These advances reinforce the climb of the 5G in healthcare market as next-generation workloads mature.

By Application: Telemedicine Dominance Faces Surgical Innovation

Telemedicine and virtual consultations captured 34.02% of 5G in healthcare market size during 2025, buoyed by pandemic-era behavioural change and stable reimbursement codes. Remote patient monitoring complements virtual visits, feeding real-time vitals to care teams via mMTC sensors. Yet robotic and telesurgery exhibit the fastest 32.75% CAGR: China’s 60-minute hepatic lobectomy performed 50 km from the patient through Huawei-powered 5G links proved that surgical dexterity survives distance. Connected ambulances, AR-assisted rehabilitation, and smart intensive-care dashboards broaden the application mix.

Integration of AI models at the network edge blurs traditional segment lines. Predictive imaging triage, automatic instrument tracking, and autonomous disinfection robots demand synchronous data, intensifying 5G bandwidth and latency requirements. As these platforms leap from trial to routine workflow, they bolster revenue diversity and attract software-centric entrants to the 5G in healthcare market.

Global 5G in Healthcare Market: Market Share by Application, 2025
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Global 5G in Healthcare Market: Market Share by Application, 2025

By End User: Hospitals Lead While Home Healthcare Surges

Hospitals and surgical centers held 45.83% of 5G in healthcare market share in 2025, justified by critical-care workloads that cannot tolerate connectivity failure. They dominate early capex by deploying private cores, edge clusters, and device orchestration platforms. Home healthcare, however, is accelerating at 33.41% CAGR as insurers push care closer to patients. Boston Children’s Hospital uses a 5G hybrid network to connect clinicians across sites, enabling future in-home treatment and AI-driven triage. Ambulatory clinics and research institutes serve as innovation labs, piloting AR-aided endoscopy and smart lab inventories.

Consumer-grade devices certified for medical use will fuel the next wave of distributed care. When hospital-quality diagnostics reach living rooms, the 5G in healthcare market widens far beyond institutional walls, reinforcing demand for secure, scalable, and standards-compliant connectivity services.

Geography Analysis

North America retained 39.78% share of the 5G in healthcare market in 2025 thanks to early private-network investments, favourable reimbursement, and strong vendor ecosystems. Cleveland Clinic’s Mentor campus illustrates rapid ROI: 5G kiosks cut admission waits and telemetry wearables freed nursing time, validating enterprise cases for peers across the US and Canada. Structured payment for video visits and RPM further lowers adoption barriers, driving near-term revenue.

Asia-Pacific delivers the fastest 34.08% CAGR through 2031 as China’s national policy aligns spectrum allocation, infrastructure subsidies, and digital-health grants. Singapore’s NUHS and Singtel deployed a hybrid enterprise network that underpins the Holomedicine program—remote holographic visualisation that shortens surgical planning—while South Korea’s Samsung Medical Centre streams 3D CT scans onto AR headsets for trainee surgeons. Economies of scale and manufacturing depth make Asia-Pacific a cost-efficient hardware base, further amplifying regional momentum.

Europe advances more gradually. Only 2% of hospitals had 5G SA coverage in 2024 compared with 80% in China and 24% in the US, due in part to fragmented regulation and vendor swap-outs prompted by security reviews. Germany leads regional deployments, and Finland’s Oulu University Hospital hosts Europe’s most mature private medical 5G SA network. The European Commission’s Digital Compass seeks ubiquitous 5G by 2030; success will require harmonised spectrum fees, streamlined permits, and public-sector anchor projects to spur rural uptake—factors that will influence the continental slice of the 5G in healthcare market.

The Middle East and Africa trail on absolute spend but show pockets of innovation: the UAE’s e& enterprise and Burjeel Holdings launched 5G telemedicine clinics, and South African providers pilot connected ambulances with real-time sonography. Latin America, led by Brazil and Mexico, extends tele-ICU grids to address specialist deficits, with coverage gains hinging on cost-effective mid-band spectrum auctions. Each emerging-market proof point enlarges the global opportunity pool, keeping the 5G in healthcare market on its steep upward trajectory.

Global 5G in Healthcare Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Regulatory Landscape

Regulation for 5G-enabled healthcare is tightening around two enforcement hotspots: cybersecure medical devices and interoperable health data exchange. In the United States, the FDA issued updated final guidance in February 2026, "Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions," raising the bar for device makers and connectivity-dependent platforms that must document security controls within premarket submissions. Interoperability requirements continue to influence deployment architectures through federal health IT rules, including the HHS HTI-2 final rule effective in 2025, which reinforces certified health information exchange pathways for telehealth and remote monitoring workflows running over 5G.

Across Europe, Regulation (EU) 2025/327 established the European Health Data Space (EHDS), creating a clearer legal and technical framework for electronic health record system use and secondary data access, which increases requirements for secure connectivity and data handling in smart hospitals. Standards bodies are also shaping procurement language for latency-sensitive use cases: ITU-T approved Recommendation G.8275.1 in February 2026 to update network timing and synchronization profiles that support deterministic performance, a prerequisite for mission-critical applications such as remote diagnostics, XR-assisted procedures, and robotics in clinical environments.

Value Chain Analysis

The value chain spans (1) spectrum access and network policy, (2) telecom infrastructure and edge compute, (3) private and public 5G connectivity services, (4) device and platform makers (medical devices, wearables, gateways, and PACS/telehealth platforms), and (5) systems integration, cybersecurity, and managed operations within provider workflows. Telecom operators and infrastructure vendors increasingly influence clinical-grade wireless designs, supplying radios and cores, network slicing, and edge orchestration that align with hospital latency and uptime requirements. Ecosystem partnerships illustrate this layering: GSMA Foundry and Singapore's National University Health System (NUHS) launched a strategic partnership in February 2026, with Ericsson and Singtel supporting connectivity and infrastructure for use cases spanning remote surgery enablement, XR training, robotics, and hospital-at-home models.

Certification and validation add a parallel compliance chain that shapes time-to-market and vendor selection for 5G-enabled medical devices, including spectrum and radio compliance, carrier acceptance processes, and regulator-aligned performance evidence. The FDA's TRUST initiative is one example of an enabling layer for evaluating 5G-enabled device performance in application-relevant scenarios. Operational bottlenecks remain concentrated in on-site RF constraints in hospitals (dense materials and complex floorplans), legacy interoperability, and the need for dependable handovers in ultra-dense deployments, which increases the role of integrators and managed service providers. On the logistics side, health systems are also consolidating procurement and distribution capabilities that depend on real-time visibility, reflected in M42 and Mubadala Bio's Global Medical Supply Chain (GMSC) signing an outsourcing agreement in May 2026 to integrate procurement, warehousing, and distribution across M42's network.

Competitive Landscape

Competition unfolds across three interlocking layers. Telecom infrastructure vendors—Huawei, Ericsson, Nokia, Qualcomm, and Samsung—supply radios, cores, and orchestration software. Healthcare technology leaders—Philips, GE Healthcare, Siemens Healthineers, Medtronic—embed clinical logic, imaging algorithms, and device integration. Systems integrators and hyperscalers bridge both worlds, packaging managed private-network services with security and analytics. This mosaic generates moderate fragmentation: no single firm exceeds 15% revenue share, yet the top five collectively command roughly 55%, underscoring a market concentration score of 6.

Partnerships dominate strategy. Verizon pairs with Cleveland Clinic to showcase private-5G reference architecture, while Cisco teams with Kajeet to roll out healthcare-specific managed services that de-risk adoption for midsized hospitals. Edge-compute alliances crop up as latency-sensitive workloads shift analytic engines closer to patient bedsides; Qualcomm and Microsoft integrate AI accelerators into hospital servers to classify imaging in real time. Regulatory collaboration also intensifies: the FDA’s 5G working group harmonises device certification, giving compliant suppliers a first-mover edge.

Sourcing dynamics evolve as hospitals seek vendor-agnostic orchestration. Open RAN pilots permit component interchangeability, pressuring incumbents to emphasise software differentiation and service quality. Cybersecurity capabilities grow decisive: providers favour partners offering zero-trust architectures, device attestation, and real-time anomaly detection. As competition shifts from pure bandwidth to packaged clinical value, the 5G in healthcare market increasingly rewards ecosystem orchestration over standalone hardware scale.

Global 5G In Healthcare Industry Leaders

  1. AT&T

  2. Verizon

  3. Ericsson

  4. T‑Mobile USA, Inc.

  5. Cisco

  6. *Disclaimer: Major Players sorted in no particular order
5G in Healthcare Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Market Opportunities and Future Outlook

Private 5G standalone (SA) networks and virtual private 5G services are moving from pilots into repeatable deployment templates, creating whitespace for managed services that bundle design, spectrum strategy, cybersecurity, and lifecycle operations. Evidence of operationalization across multiple geographies supports this shift: Oulu University Hospital operationalized a private 5G SA network in February 2026, and NUHS worked with Singtel and Ericsson on a virtual private 5G deployment (highlighted in 2026) for XR-assisted surgery, real-time clinical guidance, and remote monitoring. These deployments widen addressable budgets beyond radios and devices into recurring service contracts, edge infrastructure, and workflow integration for telemedicine, remote patient monitoring, and in-hospital IoT.

A second opportunity area sits at the intersection of standards-led quality assurance and hospital procurement requirements for clinical-grade performance. ITU-T Recommendations such as F.780.5 (published January 2024 for telemonitoring in rapid deployment hospitals) and Y.3143 (published September 2024 for QoS assurance in 5G-supported smart healthcare) provide reference points that can be translated into tender specifications for latency, availability, and service assurance. Replacement of legacy in-hospital communications is also creating a practical conversion pathway to 5G: in Austria, Gesundheit Burgenland expanded a private 5G campus network across multiple hospitals in 2025 and replaced legacy DECT and pager systems, demonstrating a near-term modernization route vendors can replicate alongside higher-end use cases such as XR in operating rooms and training centers, as seen in private 5G SA deployments at facilities such as Aretaieio University Hospital via Cosmote in 2026.

Recent Industry Developments

  • July 2026: Ericsson and AT&T, with MediaTek, completed North America's first in-field trial of Low-Latency Mobility (LTM) on the AT&T network. The work targets improved mobility performance for low-latency IoT and XR traffic, which are core enablers for clinical wearables, remote guidance, and mixed-reality training scenarios in 5G-enabled care environments.
  • June 2026: Ericsson announced that its Private 5G solution is available through Verizon Business private wireless deployments internationally. This expands channel access for hospital and health system private-network rollouts and supports bandwidth- and latency-sensitive workflows such as remote diagnostics and medical imaging across a broader set of geographies.
  • June 2025: Kajeet partnered with Cisco to deliver healthcare-specific 5G managed services aimed at turnkey deployments. The alliance reinforces the shift from one-time infrastructure projects toward packaged connectivity, security, and operations models that reduce staffing and integration burdens for hospitals.

Table of Contents for Global 5G In Healthcare Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Surging tele-ICU and remote surgery pilots
    • 4.2.2 Telecom–provider push for private 5G networks in hospitals
    • 4.2.3 Reimbursement expansion for video visits & RPM
    • 4.2.4 mMTC-enabled asset tracking cuts hospital opex
    • 4.2.5 Hyper-converged edge datacenters in smart hospitals (under-the-radar)
    • 4.2.6 AI-assisted network slicing for clinical QoS (under-the-radar)
  • 4.3 Market Restraints
    • 4.3.1 Spectrum–licensing cost burden on healthcare systems
    • 4.3.2 Cyber-physical security vulnerabilities in connected devices
    • 4.3.3 Inter-vendor interoperability gaps (under-the-radar)
    • 4.3.4 Clinician unions’ latency-liability concerns (under-the-radar)
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter’s Five Forces
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Suppliers
    • 4.7.3 Bargaining Power of Buyers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Industry Rivalry

5. Market Size & Growth Forecasts

  • 5.1 By Component (Value)
    • 5.1.1 Hardware
    • 5.1.2 Solutions & Platforms
    • 5.1.3 Services
  • 5.2 By Communication Type (Value)
    • 5.2.1 Enhanced Mobile Broadband (eMBB)
    • 5.2.2 Ultra-Reliable Low-Latency Comm. (URLLC)
    • 5.2.3 Massive Machine-Type Comm. (mMTC)
  • 5.3 By Application (Value)
    • 5.3.1 Telemedicine & Virtual Consultation
    • 5.3.2 Remote Patient Monitoring
    • 5.3.3 AR/VR Assisted Therapy & Training
    • 5.3.4 Connected Ambulance & Emergency Care
    • 5.3.5 Smart Wearables & In-Hospital IoT
    • 5.3.6 Robotic & Telesurgery
  • 5.4 By End User (Value)
    • 5.4.1 Hospitals & Surgical Centers
    • 5.4.2 Ambulatory & Specialty Clinics
    • 5.4.3 Home Healthcare Providers
    • 5.4.4 Academic & Research Institutes
  • 5.5 By Geography (Value)
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 India
    • 5.5.3.3 Japan
    • 5.5.3.4 South Korea
    • 5.5.3.5 Australia
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 South America
    • 5.5.4.1 Brazil
    • 5.5.4.2 Argentina
    • 5.5.4.3 Rest of South America
    • 5.5.5 Middle East and Africa
    • 5.5.5.1 GCC
    • 5.5.5.2 South Africa
    • 5.5.5.3 Rest of Middle East and Africa

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.3.1 Huawei Technologies
    • 6.3.2 Ericsson
    • 6.3.3 Nokia
    • 6.3.4 Qualcomm
    • 6.3.5 Samsung Electronics
    • 6.3.6 AT&T
    • 6.3.7 Verizon Communications
    • 6.3.8 China Mobile
    • 6.3.9 Deutsche Telekom
    • 6.3.10 SK Telecom
    • 6.3.11 KT Corporation
    • 6.3.12 Telstra
    • 6.3.13 Cisco Systems
    • 6.3.14 ZTE Corporation
    • 6.3.15 NEC Corporation
    • 6.3.16 Fujitsu
    • 6.3.17 Siemens Healthineers
    • 6.3.18 Philips Healthcare
    • 6.3.19 GE Healthcare
    • 6.3.20 Medtronic

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-need Assessment

Research Methodology Framework and Report Scope

Market Definition and Coverage

This market covers spending tied to using 5G connectivity to enable healthcare delivery and operations. It includes the hardware, services, and connectivity needed to run 5G-based medical workflows and connected care.

Scope exclusions: We exclude non-5G connectivity (such as Wi-Fi only deployments), and we also exclude general hospital IT upgrades that are not directly triggered by 5G use cases.

Segmentation Overview

  • By Component (Value)
    • Hardware
    • Solutions & Platforms
    • Services
  • By Communication Type (Value)
    • Enhanced Mobile Broadband (eMBB)
    • Ultra-Reliable Low-Latency Comm. (URLLC)
    • Massive Machine-Type Comm. (mMTC)
  • By Application (Value)
    • Telemedicine & Virtual Consultation
    • Remote Patient Monitoring
    • AR/VR Assisted Therapy & Training
    • Connected Ambulance & Emergency Care
    • Smart Wearables & In-Hospital IoT
    • Robotic & Telesurgery
  • By End User (Value)
    • Hospitals & Surgical Centers
    • Ambulatory & Specialty Clinics
    • Home Healthcare Providers
    • Academic & Research Institutes
  • By Geography (Value)
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa

Data Sources, Market Sizing, and Validation

Desk Research

Desk research starts by mapping what "5G-enabled" means in healthcare and where it shows up in real spending. We use public references for the anchor variables and definitions, including the FCC for spectrum context, the ITU for network standards direction, the OECD for digital health indicators, and the World Health Organization for health system and telehealth readiness signals. When country context is needed, we also refer to national telecom regulator releases and health ministry digital health programs to understand rollout timing and stated priorities.

To convert that context into model inputs, we review annual reports, 10-K style filings, and investor presentations from relevant ecosystem participants, then cross-check with reputable press and association websites focused on digital health and medical device connectivity. Paid subscriptions that support company financials and news screening, plus patent databases for tracking 5G-related healthcare innovation themes, are used selectively to confirm product focus and timelines. This list is not exhaustive, and other sources are also reviewed for data collection, validation, and clarification during analysis.

Primary Interviews and Surveys

Primary interviews and surveys are used to pressure-test adoption, budget logic, and practical deployment constraints, which are often not visible in public sources. We speak with hospital and clinic IT and operations leaders, connected device and solution stakeholders, and telecom and integration participants across APAC, EMEA, and the Americas, then re-check the most sensitive assumptions when feedback diverges. These inputs help us confirm what portion of connected care and in-facility networking activity is truly 5G-driven, and what is still running on legacy connectivity.

Distribution of primary research fieldwork respondents

Company typeRespondent positionRegion
Top tier: 31% CXOs: 15%APAC: 43%
Mid tier: 52% Functional/Unit leaders: 28%EMEA: 34%
Smaller Players: 17% Managers: 57%Americas: 23%

Market-Sizing & Forecasting

For sizing, we use top-down and bottom-up logic, but the backbone is a top-down build where healthcare connectivity and digital care demand pools are reconstructed by region and then narrowed to 5G-ready use cases. Once the pieces are in place, the main totals come from applying penetration rates of 5G into hospital networks and connected care programs, then aligning them with observed rollout timelines.

Key inputs include 5G coverage and rollout pacing, the share of hospitals and large clinics pursuing private or hybrid cellular networks, and adoption of remote patient monitoring and connected medical devices that benefit from low latency. We also use typical solution pricing patterns across hardware, services, and connectivity. Practical constraints, such as cybersecurity requirements and integration readiness, are tracked as well, since they shift deployment speed and service attach rates.

For forecasting, scenario analysis is used to handle timing risk, and then scenarios are reconciled to an expected case that primary experts view as most realistic. Where bottom-up details are incomplete, we use sampled checks such as ASP times estimated volumes for selected use cases, supported by channel feedback on deployment mix. We then adjust the top-down totals only when the variance is persistent and explainable.

Data Validation & Update Cycle

Model outputs are validated through multiple checks, including comparing implied spending per facility against what healthcare procurement cycles can reasonably support. We also compare adoption curves against independent signals such as 5G rollout milestones and reported digital care expansion, then review anomalies before internal sign-off. If a major assumption changes, for example a meaningful shift in private network deployments or policy direction, the relevant experts are re-contacted and the model is recalibrated.

The report is refreshed annually, and interim updates are made when material events change demand or pricing assumptions. Before delivery, an analyst completes a final freshness pass so the published view reflects the latest available signals and verified inputs.

Mordor Intelligence's Healthcare 5g Market Size Measured Against Other Published Estimates

Published market values for 5G in healthcare often do not match, mainly because the scope line is drawn differently and because rollout timing assumptions can be more optimistic in some studies. Differences also come from how researchers treat service attach rates, connectivity revenue attribution, and which care settings are counted as active users.

Non-5G wireless healthcare connectivity spend sits outside Mordor Intelligence's scope, which is a common reason other published totals look either smaller (if they only count narrow pilots) or much larger (if they bundle broader wireless or digital health budgets). Beyond scope, some estimates apply aggressive adoption ramps for remote monitoring and connected devices without validating what share is truly running on 5G, and they may also use simplified currency timing and price progression assumptions that can inflate a single-year value.

Benchmark comparison

SourceMarket SizeGaps in Research Methodology
Mordor Intelligence USD 95.26 B (2025)
Trade Journal A USD 85.00 B (2024)The figure is anchored to a different base year and is typically communicated as a headline snapshot, with limited visibility on whether connectivity revenue is counted separately from adjacent digital health spending.
Industry Association B USD 110.00 B (2025)The estimate appears to bundle broader wireless modernization and network equipment refresh programs across care sites, which can pull in spend that is not specifically tied to 5G-enabled healthcare use cases.

The comparison shows that most of the spread can be explained by what gets included as 5G-specific healthcare activity, followed by timing and pricing assumptions. By keeping the model tied to observable deployment signals and by separating connectivity, services, and hardware where possible, we arrive at a transparent number that can be traced back to repeatable inputs.

Key Questions Answered in the Report

What is the current Global 5G in Healthcare Market size?

The Global 5G in Healthcare Market is projected to register a CAGR of 29.74% during the forecast period (2026-2031)

Who are the key players in Global 5G in Healthcare Market?

AT&T, Verizon, Ericsson, T‑Mobile USA, Inc. and Cisco are the major companies operating in the Global 5G in Healthcare Market.

Which is the fastest growing region in Global 5G in Healthcare Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2026-2031).

Which region has the biggest share in Global 5G in Healthcare Market?

In 2025, the North America accounts for the largest market share in Global 5G in Healthcare Market.

What years does this Global 5G in Healthcare Market cover?

The report covers the Global 5G in Healthcare Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global 5G in Healthcare Market size for years: 2026, 2027, 2028, 2029, 2030 and 2031.

Page last updated on:

Global 5G In Healthcare Report Snapshots